Ad hominem attacks on 5/9 placed before data release on 5/10 were an attempt to poison the well meaning turn those who recently bought NWBO against the firm. Adam Feuerstein tried to drive a wedge between UCLA and Northwest Biotherapeutics by claiming Linda Liau was not able to attend NYAS due to trial failure.
He was successful. To the new uninformed retail shareholder, who saw this blue checkmark journalist from Statnews making inflammatory statements, the doubt had a material impact. Combine that with stop losses the event decimated the intraday market cap of Northwest Biotherapeutics before the NYAS presentation even began. This timeline isn't in dispute.
Management cannot stop a muckracking "journalist" from making potentially libelous statements nor can the government. The Supreme Court has roundly rejected prior restraint. The burden now exists on management to prove this criminal manipulation did in fact occur. I believe they have evidence in place though their primary focus remains approval for DCVax. As we know from MHRA they remain very close.
Market Data 
Markets 
AI
